Related Experiment Video
Updated: Mar 7, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.3K
TWO CASES OF THYROID COLLISION TUMORS WITH DIFFERENT DIFFERENTIATION PATHWAYS
O Kovalyov1, S Zavhorodniy1, O Tolok2
1Zaporizhzhia State Medical and Pharmaceutical University, Zaporizhzhia, Ukraine.
Experimental Oncology
|March 6, 2026
Summary
Thyroid collision tumors, rare dual cancers, present diagnostic challenges. This study details two synchronous thyroid carcinomas, highlighting the need for awareness in diagnosis and management.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thyroid collision tumors are rare entities involving two distinct neoplasms in the same anatomical region.
- Synchronous thyroid carcinomas with divergent differentiation pathways are infrequently reported.
Purpose of the Study:
- To report two cases of synchronous thyroid carcinomas presenting as collision tumors.
- To discuss the clinicopathological features, diagnostic challenges, and potential pathogenesis of these rare tumors.
Main Methods:
- Case report of two patients with synchronous thyroid carcinomas.
- Histopathological examination to confirm dual tumor composition and topographic demarcation.
- Review of clinical presentation, including history of multinodular goiter and rapid growth.
Main Results:
- Two cases confirmed as thyroid collision tumors: papillary thyroid carcinoma (PTC) with follicular carcinoma, and PTC with a poorly differentiated component.
- Both cases exhibited a history of multinodular goiter with recent rapid growth.
- Surgical total thyroidectomy was performed, and histopathology confirmed distinct neoplasms with sharp demarcation.
Conclusions:
- Thyroid collision tumors are rare but require accurate diagnosis and management.
- Potential environmental and molecular factors may contribute to divergent malignant transformation.
- Increased awareness of this phenomenon is crucial for clinicians and pathologists.
Related Concept Videos
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Synthesis and Regulation of Thyroid Hormones
8.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.5K
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K

